Context Therapeutics Inc is trading 10.2% down today at $1.53, continuing a steep downward trend that has seen the stock fall from $2.85 on May 29, 2026.
- The decline is driven by weak technical momentum and lingering investor disappointment regarding the company's full-year 2025 financial results.
- No fresh company-specific news or catalysts have emerged today; the price action appears to be exacerbated by a broader risk-off sentiment across the equity markets.